NASH Transactions by JNJ, BMS and Novartis, Highlight Continued Appetite for NASH Assets
January 06, 2017 09:30 ET
|
Immuron Limited
MELBOURNE, Australia, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Following the US$1.7B proposed takeover of Tobira by Allergan, three more Licensing Mergers & Acquisitions (LM&A) transactions over...
Enjoy Your Holiday Travel and Protect Yourself from Food-Borne Illness with Travelan
December 22, 2016 14:56 ET
|
Immuron Limited
FARMINGTON, Conn., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Immuron Limited: The latest travel forecast released this week by AAA, projects that 103 million Americans will travel during the December 23,...
Immuron Files F-1 with the SEC
December 21, 2016 21:00 ET
|
Immuron Limited
MELBOURNE, Australia, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company, Immuron Limited (ASX:IMC), is pleased to announce today that it filed its Registration Statement on Form...
Immuron Receives $1.59M R&D Tax Concession Refund
November 29, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) is pleased to announce that under the Australian Government’s Research and Development Income Tax Concession...
Protect Yourself from Contaminated Food During the 2016 Holiday Travel Season with Travelan
November 21, 2016 15:11 ET
|
Immuron Limited
FARMINGTON, Conn., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Immuron Limited: According to AAA research released this week, 48.7 million Americans are expected to travel within the U.S. this...
Immuron Announces Availability of RedChip Conference Presentation
July 25, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, July 25, 2016 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) announces the availability of its presentation from RedChip’s Small Stocks, Big Money Investor...
Immuron to Cooperate with Leading Australian Universities on Autism Research
July 20, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, July 20, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company, Immuron Limited (ASX:IMC) (OTCQB:IMROY), today announced it has formed a strategic...
Immuron Rights Issue Raises $5.33M
July 07, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, July 07, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (OTCQB:IMROY), is pleased to announce that the Company has...
Travelan to Reach Up to 1.5M New US Customers via Magellan’s
June 30, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, June 30, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (OTCQB:IMROY) is pleased to announce that Travelan will be...
Immuron Significantly Expands US Distribution Reach with McKesson Agreement
June 29, 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, June 29, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (OTCQB:IMROY), today announced that the Company has executed a...